Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX)

Historical Holders from Q4 2023 to Q1 2025

Symbol
EVAX on Nasdaq
CUSIP
29970R204
Type / Class
Equity / American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share
Shares outstanding
316M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
806K
Holdings value
$682K
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
9
Number of buys
3
Number of sells
-3
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Merck & Co., Inc. 19.96% $94.5M 63M Merck & Co., Inc. Jan 31, 2025

Institutional Holders of Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 2 $3.00 -$34K $1.50 1
2024 Q4 806K $682K -$278K $0.85 9
2024 Q3 548K $1.71M +$291K $3.11 8
2024 Q2 453K $1.31M +$206K $2.89 6
2024 Q1 381K $1.22M +$1.21M $3.20 6
2023 Q4 10K $6.86K +$6.86K $0.69 1